Reference : Use of anticoagulants and antiplatelet agents in stable outpatients with coronary art...
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/229793
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry
English
Fauchier, L. [Service de Cardiologie, Centre Hospitalier Universitaire Trousseau and Université François Rabelais, Tours, France]
Greenlaw, N. [Robertson Centre, University of Glasgow, Glasgow, United Kingdom]
Ferrari, R. [Department of Cardiology, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care and Research, E.S. Health Science Foundation, Cotignola, Italy]
Ford, I. [Robertson Centre, University of Glasgow, Glasgow, United Kingdom]
Fox, K. M. [NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom]
Tardif, J.-C. [Montreal Heart Institute, Université de Montreal, Montreal, Canada]
Tendera, M. [Medical University of Silesia, Katowice, Poland]
Steg, P. G. [NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom, Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France, INSERM U-1148, Paris, France, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France]
CLARIFY Investigators [> >]
MARTINEZ, Christophe mailto [Université de Liège - ULiège]
Li, Jianwei [Université de Liège - ULiège]
Zhang, Lihong [Université de Liège - ULiège]
Bernard, Alice [Université de Liège - ULiège]
Zhao, Yuchen [Université de Liège - ULiège]
Liu, Jian [Université de Liège - ULiège]
Dubois, Jacques [Université de Liège - ULiège]
Muller, Joséphine mailto [Université de Liège - ULiège]
Robert, Jocelyne [Université de Liège - ULiège]
Silvestre, Aude [Université de Liège - ULiège]
Lemos, Agostinho [Université de Liège - ULiège]
Doucet, Jean-Louis [Université de Liège - ULiège]
Aubry, Jean-Marie [Université de Liège - ULiège]
Robert, Jocelyne [Université de Liège - ULiège]
Chen, Yu [Université de Liège - ULiège]
Zhang, Hong [Université de Liège - ULiège]
DAVIN, Laurent mailto [Université de Liège - ULiège]
Nguyen, Laurent [Université de Liège - ULiège]
Wang, Yuan [Université de Liège - ULiège]
LANCELLOTTI, Patrizio mailto [Université de Liège - ULiège]
2015
PLoS ONE
Public Library of Science
10
4
Yes (verified by ORBi)
International
1932-6203
[en] Article ; Aged ; Anticoagulants ; Atrial Fibrillation ; Cohort Studies ; Coronary Artery Disease ; Drug Therapy, Combination ; Female ; Guideline Adherence ; Humans ; Male ; Outpatients ; Platelet Aggregation Inhibitors ; Practice Patterns, Physicians' ; Registries
[en] Background Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the prevalence of AF and its antithrombotic management in a contemporary population of patients with stable coronary artery disease. Methods and Findings CLARIFY is an international, prospective, longitudinal registry of outpatients with stable coronary artery disease, defined as prior (≥12 months) myocardial infarction, revascularization procedure, coronary stenosis >50%, or chest pain associated with evidence of myocardial ischemia. Overall, 33,428 patients were screened, of whom 32,954 had data available for analysis at baseline; of these 2,229 (6.7%) had a history of AF. Median (interquartile range) CHA2DS2-VASc score was 4 (3, 5). Oral anticoagulation alone was used in 25.7%, antiplatelet therapy alone in 52.8% (single 41.8%, dual 11.0%), and both in 21.5%. OAC use was independently associated with permanent AF (p<0.001), CHA2DS2-VASc score (p=0.006), pacemaker (p<0.001), stroke (p=0.04), absence of angina (p=0.004), decreased left ventricular ejection fraction (p<0.001), increased waist circumference (p=0.005), and longer history of coronary artery disease (p=0.008). History of percutaneous coronary intervention (p=0.004) and no/partial reimbursement for cardiovascular medication (p=0.01, p<0.001, respectively) were associated with reduced oral anticoagulant use. Conclusions In this contemporary cohort of patients with stable coronary artery disease and AF, most of whom are theoretical candidates for anticoagulation, oral anticoagulants were used in only 47.2%. Half of the patients received antiplatelet therapy alone and one-fifth received both antiplatelets and oral anticoagulants. Efforts are needed to improve adherence to guidelines in these patients. © 2015 Fauchier et al.
http://hdl.handle.net/2268/229793
10.1371/journal.pone.0125164

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
pone.0125164.pdfPublisher postprint615.02 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.